Guardian Pharmacy Services (GRDN) Depreciation & Amortization (CF) (2023 - 2026)

Guardian Pharmacy Services has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $6.0 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $6.0 million, up 13.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.0 million (up 13.58% YoY), and the FY2025 annual result was $22.3 million, up 12.96% from the prior year.
• Depreciation & Amortization (CF) came in at $6.0 million for Q1 2026 at Guardian Pharmacy Services, up from $5.7 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $6.0 million in Q1 2026 to a low of $4.7 million in Q4 2023.
• The 4-year median for Depreciation & Amortization (CF) is $5.2 million (2024), against an average of $5.3 million.
• Across the five-year window, Depreciation & Amortization (CF) gained 9.31% in 2024 and increased 16.9% in 2025, its largest moves.
• Guardian Pharmacy Services' Depreciation & Amortization (CF) stood at $4.7 million in 2023, then increased by 9.31% to $5.2 million in 2024, then gained by 11.41% to $5.7 million in 2025, then gained by 4.09% to $6.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $6.0 million (Q1 2026), $5.7 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.